What about Xi Anjansang Pharmaceutical Co., Ltd.

Xi Anjansang Pharmaceutical Co., Ltd. is the largest joint venture pharmaceutical enterprise in China and the largest subsidiary of Johnson & Johnson Company in China. Founded in 1985, it is headquartered in Beijing, with its production base in Xi 'an and more than 3,000 employees in China. The company's business includes the production and sale of high-quality drugs. Products mainly involve gastroenterology, neuropsychiatry, allergy, pain management, anti-infection, biological agents and tumors. In addition, the company is also committed to providing health-related services and carrying out public health education. Xi Jansen produces 15 kinds of patented drugs, involving mycology, gastroenterology, psychiatry, neurology and other fields.

Legal Representative: Asgar David Landsborough Gonwala.

Established: 1985- 10-22.

Registered capital: RMB 284,365,438+0.765,438+0.64 million.

Industrial and commercial registration number: 6 1000040000699

Type of enterprise: limited liability company (Sino-foreign joint venture)

Company address: No.34 Wanshou North Road, xincheng District, Xi City, Shaanxi Province/No.4 Caotang Road, Caotang Science and Technology Industrial Base, Xi High-tech Zone, Shaanxi Province 19.